nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—melanoma	0.423	1	CbGaD
Rasagiline—BCL2—Docetaxel—melanoma	0.291	0.743	CbGbCtD
Rasagiline—CYP1A2—Carmustine—melanoma	0.042	0.107	CbGbCtD
Rasagiline—CYP1A2—Vemurafenib—melanoma	0.0332	0.0847	CbGbCtD
Rasagiline—CYP1A2—Dacarbazine—melanoma	0.0254	0.0649	CbGbCtD
Rasagiline—Body temperature increased—Vemurafenib—melanoma	0.00017	0.00193	CcSEcCtD
Rasagiline—Neuropathy peripheral—Temozolomide—melanoma	0.000169	0.00192	CcSEcCtD
Rasagiline—Stomatitis—Temozolomide—melanoma	0.000168	0.00191	CcSEcCtD
Rasagiline—Deafness—Docetaxel—melanoma	0.000167	0.00189	CcSEcCtD
Rasagiline—Chills—Bleomycin—melanoma	0.000165	0.00187	CcSEcCtD
Rasagiline—Alopecia—Bleomycin—melanoma	0.000163	0.00184	CcSEcCtD
Rasagiline—Haemoglobin—Carmustine—melanoma	0.000161	0.00183	CcSEcCtD
Rasagiline—Haemorrhage—Carmustine—melanoma	0.000161	0.00182	CcSEcCtD
Rasagiline—Hypoaesthesia—Carmustine—melanoma	0.00016	0.00181	CcSEcCtD
Rasagiline—Hallucination—Carmustine—melanoma	0.00016	0.00181	CcSEcCtD
Rasagiline—Hypersensitivity—Vemurafenib—melanoma	0.000159	0.0018	CcSEcCtD
Rasagiline—Oedema peripheral—Carmustine—melanoma	0.000158	0.00179	CcSEcCtD
Rasagiline—Connective tissue disorder—Carmustine—melanoma	0.000158	0.00179	CcSEcCtD
Rasagiline—Dermatitis bullous—Docetaxel—melanoma	0.000156	0.00177	CcSEcCtD
Rasagiline—Haemoglobin—Temozolomide—melanoma	0.000156	0.00177	CcSEcCtD
Rasagiline—Haemorrhage—Temozolomide—melanoma	0.000155	0.00176	CcSEcCtD
Rasagiline—Asthenia—Vemurafenib—melanoma	0.000155	0.00175	CcSEcCtD
Rasagiline—Hypoaesthesia—Temozolomide—melanoma	0.000154	0.00175	CcSEcCtD
Rasagiline—Hallucination—Temozolomide—melanoma	0.000154	0.00175	CcSEcCtD
Rasagiline—Chills—Dactinomycin—melanoma	0.000154	0.00175	CcSEcCtD
Rasagiline—Urinary tract disorder—Temozolomide—melanoma	0.000153	0.00174	CcSEcCtD
Rasagiline—Oedema peripheral—Temozolomide—melanoma	0.000153	0.00173	CcSEcCtD
Rasagiline—Cardiac failure—Docetaxel—melanoma	0.000153	0.00173	CcSEcCtD
Rasagiline—Pruritus—Vemurafenib—melanoma	0.000153	0.00173	CcSEcCtD
Rasagiline—Connective tissue disorder—Temozolomide—melanoma	0.000152	0.00173	CcSEcCtD
Rasagiline—Urethral disorder—Temozolomide—melanoma	0.000152	0.00172	CcSEcCtD
Rasagiline—Alopecia—Dactinomycin—melanoma	0.000152	0.00172	CcSEcCtD
Rasagiline—Eye disorder—Carmustine—melanoma	0.00015	0.0017	CcSEcCtD
Rasagiline—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000149	0.00169	CcSEcCtD
Rasagiline—Ill-defined disorder—Bleomycin—melanoma	0.000149	0.00168	CcSEcCtD
Rasagiline—Anaemia—Bleomycin—melanoma	0.000148	0.00168	CcSEcCtD
Rasagiline—Diarrhoea—Vemurafenib—melanoma	0.000148	0.00167	CcSEcCtD
Rasagiline—Migraine—Docetaxel—melanoma	0.000147	0.00166	CcSEcCtD
Rasagiline—Eye disorder—Temozolomide—melanoma	0.000145	0.00164	CcSEcCtD
Rasagiline—Malaise—Bleomycin—melanoma	0.000144	0.00164	CcSEcCtD
Rasagiline—Cardiac disorder—Temozolomide—melanoma	0.000144	0.00163	CcSEcCtD
Rasagiline—Leukopenia—Bleomycin—melanoma	0.000143	0.00162	CcSEcCtD
Rasagiline—Dizziness—Vemurafenib—melanoma	0.000143	0.00162	CcSEcCtD
Rasagiline—Alopecia—Carmustine—melanoma	0.000142	0.00161	CcSEcCtD
Rasagiline—Angiopathy—Temozolomide—melanoma	0.000141	0.0016	CcSEcCtD
Rasagiline—Mental disorder—Carmustine—melanoma	0.000141	0.00159	CcSEcCtD
Rasagiline—Ataxia—Docetaxel—melanoma	0.00014	0.00159	CcSEcCtD
Rasagiline—Immune system disorder—Temozolomide—melanoma	0.00014	0.00159	CcSEcCtD
Rasagiline—Mediastinal disorder—Temozolomide—melanoma	0.00014	0.00159	CcSEcCtD
Rasagiline—Malnutrition—Carmustine—melanoma	0.00014	0.00158	CcSEcCtD
Rasagiline—Cough—Bleomycin—melanoma	0.00014	0.00158	CcSEcCtD
Rasagiline—Chills—Temozolomide—melanoma	0.000139	0.00158	CcSEcCtD
Rasagiline—Ill-defined disorder—Dactinomycin—melanoma	0.000139	0.00157	CcSEcCtD
Rasagiline—Anaemia—Dactinomycin—melanoma	0.000138	0.00156	CcSEcCtD
Rasagiline—Liver function test abnormal—Docetaxel—melanoma	0.000138	0.00156	CcSEcCtD
Rasagiline—Vomiting—Vemurafenib—melanoma	0.000137	0.00155	CcSEcCtD
Rasagiline—Alopecia—Temozolomide—melanoma	0.000137	0.00155	CcSEcCtD
Rasagiline—Chest pain—Bleomycin—melanoma	0.000136	0.00155	CcSEcCtD
Rasagiline—Orthostatic hypotension—Docetaxel—melanoma	0.000136	0.00154	CcSEcCtD
Rasagiline—Rash—Vemurafenib—melanoma	0.000136	0.00154	CcSEcCtD
Rasagiline—Mental disorder—Temozolomide—melanoma	0.000136	0.00154	CcSEcCtD
Rasagiline—Dermatitis—Vemurafenib—melanoma	0.000136	0.00154	CcSEcCtD
Rasagiline—Back pain—Carmustine—melanoma	0.000135	0.00153	CcSEcCtD
Rasagiline—Headache—Vemurafenib—melanoma	0.000135	0.00153	CcSEcCtD
Rasagiline—Malnutrition—Temozolomide—melanoma	0.000135	0.00153	CcSEcCtD
Rasagiline—Discomfort—Bleomycin—melanoma	0.000135	0.00153	CcSEcCtD
Rasagiline—Malaise—Dactinomycin—melanoma	0.000135	0.00153	CcSEcCtD
Rasagiline—Leukopenia—Dactinomycin—melanoma	0.000134	0.00152	CcSEcCtD
Rasagiline—Dysgeusia—Temozolomide—melanoma	0.000132	0.0015	CcSEcCtD
Rasagiline—Confusional state—Bleomycin—melanoma	0.000132	0.00149	CcSEcCtD
Rasagiline—Tremor—Carmustine—melanoma	0.000131	0.00148	CcSEcCtD
Rasagiline—Back pain—Temozolomide—melanoma	0.000131	0.00148	CcSEcCtD
Rasagiline—Infection—Bleomycin—melanoma	0.00013	0.00147	CcSEcCtD
Rasagiline—Anaemia—Carmustine—melanoma	0.000129	0.00146	CcSEcCtD
Rasagiline—Dysphagia—Docetaxel—melanoma	0.000129	0.00146	CcSEcCtD
Rasagiline—Agitation—Carmustine—melanoma	0.000128	0.00146	CcSEcCtD
Rasagiline—Nausea—Vemurafenib—melanoma	0.000128	0.00145	CcSEcCtD
Rasagiline—Tremor—Temozolomide—melanoma	0.000127	0.00143	CcSEcCtD
Rasagiline—Discomfort—Dactinomycin—melanoma	0.000126	0.00142	CcSEcCtD
Rasagiline—Angina pectoris—Docetaxel—melanoma	0.000126	0.00142	CcSEcCtD
Rasagiline—Ill-defined disorder—Temozolomide—melanoma	0.000125	0.00142	CcSEcCtD
Rasagiline—Leukopenia—Carmustine—melanoma	0.000125	0.00142	CcSEcCtD
Rasagiline—Anaemia—Temozolomide—melanoma	0.000125	0.00142	CcSEcCtD
Rasagiline—Anorexia—Bleomycin—melanoma	0.000125	0.00141	CcSEcCtD
Rasagiline—Agitation—Temozolomide—melanoma	0.000124	0.00141	CcSEcCtD
Rasagiline—Hypotension—Bleomycin—melanoma	0.000122	0.00138	CcSEcCtD
Rasagiline—Malaise—Temozolomide—melanoma	0.000122	0.00138	CcSEcCtD
Rasagiline—Vertigo—Temozolomide—melanoma	0.000121	0.00138	CcSEcCtD
Rasagiline—Convulsion—Carmustine—melanoma	0.000121	0.00137	CcSEcCtD
Rasagiline—Infection—Dactinomycin—melanoma	0.000121	0.00137	CcSEcCtD
Rasagiline—Leukopenia—Temozolomide—melanoma	0.000121	0.00137	CcSEcCtD
Rasagiline—Hypertension—Carmustine—melanoma	0.000121	0.00137	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Bleomycin—melanoma	0.000119	0.00135	CcSEcCtD
Rasagiline—Chest pain—Carmustine—melanoma	0.000119	0.00135	CcSEcCtD
Rasagiline—Anxiety—Carmustine—melanoma	0.000119	0.00134	CcSEcCtD
Rasagiline—Cough—Temozolomide—melanoma	0.000118	0.00134	CcSEcCtD
Rasagiline—Paraesthesia—Bleomycin—melanoma	0.000117	0.00133	CcSEcCtD
Rasagiline—Convulsion—Temozolomide—melanoma	0.000117	0.00133	CcSEcCtD
Rasagiline—Weight decreased—Docetaxel—melanoma	0.000117	0.00132	CcSEcCtD
Rasagiline—Hypertension—Temozolomide—melanoma	0.000117	0.00132	CcSEcCtD
Rasagiline—Dyspnoea—Bleomycin—melanoma	0.000116	0.00132	CcSEcCtD
Rasagiline—Anorexia—Dactinomycin—melanoma	0.000116	0.00132	CcSEcCtD
Rasagiline—Confusional state—Carmustine—melanoma	0.000115	0.0013	CcSEcCtD
Rasagiline—Arthralgia—Temozolomide—melanoma	0.000115	0.0013	CcSEcCtD
Rasagiline—Infestation—Docetaxel—melanoma	0.000115	0.0013	CcSEcCtD
Rasagiline—Infestation NOS—Docetaxel—melanoma	0.000115	0.0013	CcSEcCtD
Rasagiline—Anxiety—Temozolomide—melanoma	0.000115	0.0013	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000114	0.00129	CcSEcCtD
Rasagiline—Discomfort—Temozolomide—melanoma	0.000114	0.00129	CcSEcCtD
Rasagiline—Decreased appetite—Bleomycin—melanoma	0.000114	0.00129	CcSEcCtD
Rasagiline—Infection—Carmustine—melanoma	0.000113	0.00128	CcSEcCtD
Rasagiline—Acute coronary syndrome—Docetaxel—melanoma	0.000113	0.00128	CcSEcCtD
Rasagiline—Myocardial infarction—Docetaxel—melanoma	0.000113	0.00128	CcSEcCtD
Rasagiline—Neuropathy peripheral—Docetaxel—melanoma	0.000113	0.00128	CcSEcCtD
Rasagiline—Dry mouth—Temozolomide—melanoma	0.000112	0.00128	CcSEcCtD
Rasagiline—Stomatitis—Docetaxel—melanoma	0.000112	0.00127	CcSEcCtD
Rasagiline—Jaundice—Docetaxel—melanoma	0.000112	0.00127	CcSEcCtD
Rasagiline—Conjunctivitis—Docetaxel—melanoma	0.000112	0.00127	CcSEcCtD
Rasagiline—Confusional state—Temozolomide—melanoma	0.000111	0.00126	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000111	0.00126	CcSEcCtD
Rasagiline—Infection—Temozolomide—melanoma	0.000109	0.00124	CcSEcCtD
Rasagiline—Anorexia—Carmustine—melanoma	0.000109	0.00123	CcSEcCtD
Rasagiline—Epistaxis—Docetaxel—melanoma	0.000108	0.00123	CcSEcCtD
Rasagiline—Nervous system disorder—Temozolomide—melanoma	0.000108	0.00123	CcSEcCtD
Rasagiline—Feeling abnormal—Bleomycin—melanoma	0.000108	0.00122	CcSEcCtD
Rasagiline—Skin disorder—Temozolomide—melanoma	0.000107	0.00121	CcSEcCtD
Rasagiline—Hypotension—Carmustine—melanoma	0.000107	0.00121	CcSEcCtD
Rasagiline—Hyperhidrosis—Temozolomide—melanoma	0.000107	0.00121	CcSEcCtD
Rasagiline—Decreased appetite—Dactinomycin—melanoma	0.000106	0.0012	CcSEcCtD
Rasagiline—Anorexia—Temozolomide—melanoma	0.000105	0.00119	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Carmustine—melanoma	0.000104	0.00118	CcSEcCtD
Rasagiline—Urticaria—Bleomycin—melanoma	0.000104	0.00118	CcSEcCtD
Rasagiline—Haemoglobin—Docetaxel—melanoma	0.000104	0.00118	CcSEcCtD
Rasagiline—Rhinitis—Docetaxel—melanoma	0.000103	0.00117	CcSEcCtD
Rasagiline—Body temperature increased—Bleomycin—melanoma	0.000103	0.00117	CcSEcCtD
Rasagiline—Haemorrhage—Docetaxel—melanoma	0.000103	0.00117	CcSEcCtD
Rasagiline—Insomnia—Carmustine—melanoma	0.000103	0.00117	CcSEcCtD
Rasagiline—Hypoaesthesia—Docetaxel—melanoma	0.000103	0.00116	CcSEcCtD
Rasagiline—Paraesthesia—Carmustine—melanoma	0.000102	0.00116	CcSEcCtD
Rasagiline—Urinary tract disorder—Docetaxel—melanoma	0.000102	0.00116	CcSEcCtD
Rasagiline—Dyspnoea—Carmustine—melanoma	0.000102	0.00115	CcSEcCtD
Rasagiline—Oedema peripheral—Docetaxel—melanoma	0.000102	0.00115	CcSEcCtD
Rasagiline—Somnolence—Carmustine—melanoma	0.000101	0.00115	CcSEcCtD
Rasagiline—Connective tissue disorder—Docetaxel—melanoma	0.000101	0.00115	CcSEcCtD
Rasagiline—Urethral disorder—Docetaxel—melanoma	0.000101	0.00115	CcSEcCtD
Rasagiline—Feeling abnormal—Dactinomycin—melanoma	0.0001	0.00114	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Temozolomide—melanoma	0.0001	0.00114	CcSEcCtD
Rasagiline—Insomnia—Temozolomide—melanoma	9.97e-05	0.00113	CcSEcCtD
Rasagiline—Gastrointestinal pain—Dactinomycin—melanoma	9.96e-05	0.00113	CcSEcCtD
Rasagiline—Decreased appetite—Carmustine—melanoma	9.91e-05	0.00112	CcSEcCtD
Rasagiline—Paraesthesia—Temozolomide—melanoma	9.9e-05	0.00112	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Carmustine—melanoma	9.85e-05	0.00112	CcSEcCtD
Rasagiline—Dyspnoea—Temozolomide—melanoma	9.83e-05	0.00111	CcSEcCtD
Rasagiline—Somnolence—Temozolomide—melanoma	9.8e-05	0.00111	CcSEcCtD
Rasagiline—Constipation—Carmustine—melanoma	9.75e-05	0.00111	CcSEcCtD
Rasagiline—Dyspepsia—Temozolomide—melanoma	9.7e-05	0.0011	CcSEcCtD
Rasagiline—Eye disorder—Docetaxel—melanoma	9.64e-05	0.00109	CcSEcCtD
Rasagiline—Body temperature increased—Dactinomycin—melanoma	9.63e-05	0.00109	CcSEcCtD
Rasagiline—Abdominal pain—Dactinomycin—melanoma	9.63e-05	0.00109	CcSEcCtD
Rasagiline—Hypersensitivity—Bleomycin—melanoma	9.63e-05	0.00109	CcSEcCtD
Rasagiline—Decreased appetite—Temozolomide—melanoma	9.58e-05	0.00109	CcSEcCtD
Rasagiline—Cardiac disorder—Docetaxel—melanoma	9.57e-05	0.00109	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Temozolomide—melanoma	9.51e-05	0.00108	CcSEcCtD
Rasagiline—Constipation—Temozolomide—melanoma	9.42e-05	0.00107	CcSEcCtD
Rasagiline—Feeling abnormal—Carmustine—melanoma	9.4e-05	0.00107	CcSEcCtD
Rasagiline—Asthenia—Bleomycin—melanoma	9.37e-05	0.00106	CcSEcCtD
Rasagiline—Angiopathy—Docetaxel—melanoma	9.36e-05	0.00106	CcSEcCtD
Rasagiline—Gastrointestinal pain—Carmustine—melanoma	9.33e-05	0.00106	CcSEcCtD
Rasagiline—Immune system disorder—Docetaxel—melanoma	9.32e-05	0.00106	CcSEcCtD
Rasagiline—Mediastinal disorder—Docetaxel—melanoma	9.3e-05	0.00105	CcSEcCtD
Rasagiline—Chills—Docetaxel—melanoma	9.26e-05	0.00105	CcSEcCtD
Rasagiline—Pruritus—Bleomycin—melanoma	9.24e-05	0.00105	CcSEcCtD
Rasagiline—Alopecia—Docetaxel—melanoma	9.12e-05	0.00103	CcSEcCtD
Rasagiline—Feeling abnormal—Temozolomide—melanoma	9.08e-05	0.00103	CcSEcCtD
Rasagiline—Mental disorder—Docetaxel—melanoma	9.04e-05	0.00102	CcSEcCtD
Rasagiline—Abdominal pain—Carmustine—melanoma	9.02e-05	0.00102	CcSEcCtD
Rasagiline—Body temperature increased—Carmustine—melanoma	9.02e-05	0.00102	CcSEcCtD
Rasagiline—Gastrointestinal pain—Temozolomide—melanoma	9.01e-05	0.00102	CcSEcCtD
Rasagiline—Malnutrition—Docetaxel—melanoma	8.98e-05	0.00102	CcSEcCtD
Rasagiline—Hypersensitivity—Dactinomycin—melanoma	8.98e-05	0.00102	CcSEcCtD
Rasagiline—Dysgeusia—Docetaxel—melanoma	8.79e-05	0.000997	CcSEcCtD
Rasagiline—Urticaria—Temozolomide—melanoma	8.76e-05	0.000993	CcSEcCtD
Rasagiline—Asthenia—Dactinomycin—melanoma	8.74e-05	0.000991	CcSEcCtD
Rasagiline—Abdominal pain—Temozolomide—melanoma	8.71e-05	0.000988	CcSEcCtD
Rasagiline—Body temperature increased—Temozolomide—melanoma	8.71e-05	0.000988	CcSEcCtD
Rasagiline—Back pain—Docetaxel—melanoma	8.69e-05	0.000985	CcSEcCtD
Rasagiline—Muscle spasms—Docetaxel—melanoma	8.63e-05	0.000979	CcSEcCtD
Rasagiline—Hypersensitivity—Carmustine—melanoma	8.4e-05	0.000953	CcSEcCtD
Rasagiline—Diarrhoea—Dactinomycin—melanoma	8.34e-05	0.000945	CcSEcCtD
Rasagiline—Vomiting—Bleomycin—melanoma	8.31e-05	0.000942	CcSEcCtD
Rasagiline—Anaemia—Docetaxel—melanoma	8.3e-05	0.000941	CcSEcCtD
Rasagiline—Rash—Bleomycin—melanoma	8.24e-05	0.000934	CcSEcCtD
Rasagiline—Dermatitis—Bleomycin—melanoma	8.23e-05	0.000933	CcSEcCtD
Rasagiline—Asthenia—Carmustine—melanoma	8.18e-05	0.000928	CcSEcCtD
Rasagiline—Hypersensitivity—Temozolomide—melanoma	8.12e-05	0.000921	CcSEcCtD
Rasagiline—Syncope—Docetaxel—melanoma	8.05e-05	0.000913	CcSEcCtD
Rasagiline—Leukopenia—Docetaxel—melanoma	8.04e-05	0.000912	CcSEcCtD
Rasagiline—Asthenia—Temozolomide—melanoma	7.91e-05	0.000897	CcSEcCtD
Rasagiline—Loss of consciousness—Docetaxel—melanoma	7.89e-05	0.000895	CcSEcCtD
Rasagiline—Cough—Docetaxel—melanoma	7.84e-05	0.000889	CcSEcCtD
Rasagiline—Diarrhoea—Carmustine—melanoma	7.8e-05	0.000885	CcSEcCtD
Rasagiline—Pruritus—Temozolomide—melanoma	7.8e-05	0.000884	CcSEcCtD
Rasagiline—Convulsion—Docetaxel—melanoma	7.78e-05	0.000882	CcSEcCtD
Rasagiline—Nausea—Bleomycin—melanoma	7.76e-05	0.00088	CcSEcCtD
Rasagiline—Hypertension—Docetaxel—melanoma	7.75e-05	0.000879	CcSEcCtD
Rasagiline—Vomiting—Dactinomycin—melanoma	7.75e-05	0.000879	CcSEcCtD
Rasagiline—Rash—Dactinomycin—melanoma	7.68e-05	0.000871	CcSEcCtD
Rasagiline—Arthralgia—Docetaxel—melanoma	7.65e-05	0.000867	CcSEcCtD
Rasagiline—Chest pain—Docetaxel—melanoma	7.65e-05	0.000867	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	7.59e-05	0.000861	CcSEcCtD
Rasagiline—Dizziness—Carmustine—melanoma	7.54e-05	0.000855	CcSEcCtD
Rasagiline—Diarrhoea—Temozolomide—melanoma	7.54e-05	0.000855	CcSEcCtD
Rasagiline—Dry mouth—Docetaxel—melanoma	7.48e-05	0.000848	CcSEcCtD
Rasagiline—Confusional state—Docetaxel—melanoma	7.39e-05	0.000838	CcSEcCtD
Rasagiline—Dizziness—Temozolomide—melanoma	7.29e-05	0.000826	CcSEcCtD
Rasagiline—Infection—Docetaxel—melanoma	7.28e-05	0.000826	CcSEcCtD
Rasagiline—Vomiting—Carmustine—melanoma	7.25e-05	0.000822	CcSEcCtD
Rasagiline—Nausea—Dactinomycin—melanoma	7.24e-05	0.000821	CcSEcCtD
Rasagiline—Shock—Docetaxel—melanoma	7.21e-05	0.000818	CcSEcCtD
Rasagiline—Rash—Carmustine—melanoma	7.19e-05	0.000815	CcSEcCtD
Rasagiline—Nervous system disorder—Docetaxel—melanoma	7.19e-05	0.000815	CcSEcCtD
Rasagiline—Dermatitis—Carmustine—melanoma	7.18e-05	0.000815	CcSEcCtD
Rasagiline—Headache—Carmustine—melanoma	7.14e-05	0.00081	CcSEcCtD
Rasagiline—Skin disorder—Docetaxel—melanoma	7.12e-05	0.000807	CcSEcCtD
Rasagiline—Vomiting—Temozolomide—melanoma	7.01e-05	0.000795	CcSEcCtD
Rasagiline—Anorexia—Docetaxel—melanoma	6.99e-05	0.000792	CcSEcCtD
Rasagiline—Rash—Temozolomide—melanoma	6.95e-05	0.000788	CcSEcCtD
Rasagiline—Dermatitis—Temozolomide—melanoma	6.94e-05	0.000787	CcSEcCtD
Rasagiline—Headache—Temozolomide—melanoma	6.9e-05	0.000783	CcSEcCtD
Rasagiline—Hypotension—Docetaxel—melanoma	6.85e-05	0.000777	CcSEcCtD
Rasagiline—Nausea—Carmustine—melanoma	6.77e-05	0.000768	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Docetaxel—melanoma	6.68e-05	0.000757	CcSEcCtD
Rasagiline—Insomnia—Docetaxel—melanoma	6.63e-05	0.000752	CcSEcCtD
Rasagiline—Paraesthesia—Docetaxel—melanoma	6.58e-05	0.000746	CcSEcCtD
Rasagiline—Nausea—Temozolomide—melanoma	6.55e-05	0.000742	CcSEcCtD
Rasagiline—Dyspnoea—Docetaxel—melanoma	6.53e-05	0.000741	CcSEcCtD
Rasagiline—Somnolence—Docetaxel—melanoma	6.52e-05	0.000739	CcSEcCtD
Rasagiline—Dyspepsia—Docetaxel—melanoma	6.45e-05	0.000732	CcSEcCtD
Rasagiline—Decreased appetite—Docetaxel—melanoma	6.37e-05	0.000722	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Docetaxel—melanoma	6.33e-05	0.000718	CcSEcCtD
Rasagiline—Constipation—Docetaxel—melanoma	6.27e-05	0.000711	CcSEcCtD
Rasagiline—Feeling abnormal—Docetaxel—melanoma	6.04e-05	0.000685	CcSEcCtD
Rasagiline—Gastrointestinal pain—Docetaxel—melanoma	5.99e-05	0.00068	CcSEcCtD
Rasagiline—Abdominal pain—Docetaxel—melanoma	5.79e-05	0.000657	CcSEcCtD
Rasagiline—Body temperature increased—Docetaxel—melanoma	5.79e-05	0.000657	CcSEcCtD
Rasagiline—Hypersensitivity—Docetaxel—melanoma	5.4e-05	0.000612	CcSEcCtD
Rasagiline—Asthenia—Docetaxel—melanoma	5.26e-05	0.000596	CcSEcCtD
Rasagiline—Pruritus—Docetaxel—melanoma	5.19e-05	0.000588	CcSEcCtD
Rasagiline—Diarrhoea—Docetaxel—melanoma	5.01e-05	0.000569	CcSEcCtD
Rasagiline—Dizziness—Docetaxel—melanoma	4.85e-05	0.00055	CcSEcCtD
Rasagiline—Vomiting—Docetaxel—melanoma	4.66e-05	0.000528	CcSEcCtD
Rasagiline—Rash—Docetaxel—melanoma	4.62e-05	0.000524	CcSEcCtD
Rasagiline—Dermatitis—Docetaxel—melanoma	4.62e-05	0.000524	CcSEcCtD
Rasagiline—Headache—Docetaxel—melanoma	4.59e-05	0.000521	CcSEcCtD
Rasagiline—Nausea—Docetaxel—melanoma	4.35e-05	0.000494	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—EGFR—melanoma	3.86e-05	0.000395	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CCND1—melanoma	3.85e-05	0.000395	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP10—melanoma	3.84e-05	0.000394	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	3.84e-05	0.000394	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.83e-05	0.000393	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—melanoma	3.83e-05	0.000392	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CTNNB1—melanoma	3.81e-05	0.000391	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—SYK—melanoma	3.81e-05	0.000391	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.8e-05	0.000389	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—HRAS—melanoma	3.78e-05	0.000388	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT3—melanoma	3.74e-05	0.000384	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—melanoma	3.73e-05	0.000383	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PTEN—melanoma	3.72e-05	0.000381	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MYC—melanoma	3.71e-05	0.000381	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.71e-05	0.00038	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.7e-05	0.000379	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PHGDH—melanoma	3.69e-05	0.000378	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LUM—melanoma	3.69e-05	0.000378	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.68e-05	0.000378	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	3.68e-05	0.000377	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IFNA2—melanoma	3.66e-05	0.000375	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	3.65e-05	0.000374	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MAPK1—melanoma	3.63e-05	0.000372	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—EGFR—melanoma	3.63e-05	0.000372	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HPSE—melanoma	3.62e-05	0.000371	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CUBN—melanoma	3.55e-05	0.000364	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PLA2G6—melanoma	3.55e-05	0.000364	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—SOCS1—melanoma	3.47e-05	0.000355	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—S100B—melanoma	3.46e-05	0.000354	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SDHD—melanoma	3.43e-05	0.000352	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CSPG4—melanoma	3.43e-05	0.000352	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—BSG—melanoma	3.43e-05	0.000352	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—KRAS—melanoma	3.43e-05	0.000352	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—melanoma	3.39e-05	0.000347	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—VEGFA—melanoma	3.36e-05	0.000344	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.34e-05	0.000343	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—melanoma	3.34e-05	0.000343	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GPAM—melanoma	3.32e-05	0.000341	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB4—melanoma	3.31e-05	0.000339	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	3.29e-05	0.000338	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—MDM2—melanoma	3.28e-05	0.000336	CbGpPWpGaD
Rasagiline—BCL2—Immune System—LGALS3—melanoma	3.24e-05	0.000332	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—melanoma	3.24e-05	0.000332	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD86—melanoma	3.17e-05	0.000325	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.16e-05	0.000324	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	3.16e-05	0.000324	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.08e-05	0.000315	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FGF1—melanoma	3.07e-05	0.000315	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFIH1—melanoma	3.07e-05	0.000315	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—melanoma	3.05e-05	0.000313	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MAPK1—melanoma	3.02e-05	0.00031	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—EGFR—melanoma	3.02e-05	0.00031	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.01e-05	0.000309	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.01e-05	0.000308	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	2.99e-05	0.000307	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	2.99e-05	0.000307	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—melanoma	2.99e-05	0.000306	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PDGFRA—melanoma	2.98e-05	0.000305	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HLA-B—melanoma	2.96e-05	0.000303	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	2.95e-05	0.000303	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PRKCA—melanoma	2.95e-05	0.000302	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	2.93e-05	0.0003	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP17A1—melanoma	2.9e-05	0.000297	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAP2K2—melanoma	2.88e-05	0.000295	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.87e-05	0.000294	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	2.86e-05	0.000293	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR3—melanoma	2.84e-05	0.000291	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.84e-05	0.000291	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLA2G6—melanoma	2.83e-05	0.00029	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SKP2—melanoma	2.78e-05	0.000285	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	2.76e-05	0.000283	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	2.74e-05	0.000281	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—RAC1—melanoma	2.73e-05	0.00028	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PIK3CA—melanoma	2.62e-05	0.000269	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTK2B—melanoma	2.61e-05	0.000268	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.61e-05	0.000268	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HSPA5—melanoma	2.6e-05	0.000267	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—melanoma	2.57e-05	0.000264	CbGpPWpGaD
Rasagiline—BCL2—Immune System—GAB2—melanoma	2.54e-05	0.000261	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—VCAN—melanoma	2.54e-05	0.00026	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.53e-05	0.000259	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—melanoma	2.52e-05	0.000258	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR4—melanoma	2.51e-05	0.000257	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	2.49e-05	0.000255	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	2.46e-05	0.000252	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP1B1—melanoma	2.44e-05	0.00025	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—HRAS—melanoma	2.43e-05	0.000249	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	2.41e-05	0.000247	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FOXO4—melanoma	2.39e-05	0.000245	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD44—melanoma	2.36e-05	0.000242	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ITGA4—melanoma	2.36e-05	0.000242	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNB1—melanoma	2.35e-05	0.00024	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTLA4—melanoma	2.33e-05	0.000239	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD80—melanoma	2.31e-05	0.000237	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—KIT—melanoma	2.31e-05	0.000237	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	2.29e-05	0.000235	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNA1—melanoma	2.29e-05	0.000235	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EGF—melanoma	2.28e-05	0.000234	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	2.24e-05	0.00023	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	2.24e-05	0.00023	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	2.24e-05	0.00023	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SYK—melanoma	2.22e-05	0.000228	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	2.21e-05	0.000227	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ITGAV—melanoma	2.18e-05	0.000224	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT3—melanoma	2.18e-05	0.000224	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CASP8—melanoma	2.15e-05	0.00022	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—melanoma	2.14e-05	0.00022	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP17A1—melanoma	2.14e-05	0.00022	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.13e-05	0.000219	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	2.13e-05	0.000219	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	2.13e-05	0.000219	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNA2—melanoma	2.13e-05	0.000218	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	2.11e-05	0.000217	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAP2K1—melanoma	2.04e-05	0.000209	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PIK3CD—melanoma	2.03e-05	0.000208	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GNA11—melanoma	2.02e-05	0.000207	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SOCS1—melanoma	2.02e-05	0.000207	CbGpPWpGaD
Rasagiline—BCL2—Immune System—S100B—melanoma	2.01e-05	0.000206	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ITGB1—melanoma	1.98e-05	0.000203	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—FASN—melanoma	1.98e-05	0.000203	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC5A5—melanoma	1.95e-05	0.0002	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FGF2—melanoma	1.94e-05	0.000199	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB4—melanoma	1.93e-05	0.000197	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GNAQ—melanoma	1.88e-05	0.000193	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CD44—melanoma	1.88e-05	0.000193	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	1.85e-05	0.000189	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD86—melanoma	1.85e-05	0.000189	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MDM2—melanoma	1.82e-05	0.000186	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HGF—melanoma	1.81e-05	0.000186	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1B1—melanoma	1.8e-05	0.000185	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	1.8e-05	0.000184	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB2—melanoma	1.79e-05	0.000184	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CSF2—melanoma	1.79e-05	0.000184	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FGF1—melanoma	1.79e-05	0.000184	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD8A—melanoma	1.79e-05	0.000184	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PIK3CB—melanoma	1.77e-05	0.000181	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD4—melanoma	1.77e-05	0.000181	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PDGFRA—melanoma	1.73e-05	0.000178	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	1.73e-05	0.000177	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-B—melanoma	1.72e-05	0.000177	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRKCA—melanoma	1.72e-05	0.000176	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAP2K2—melanoma	1.68e-05	0.000172	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CDKN1B—melanoma	1.66e-05	0.00017	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ACER3—melanoma	1.63e-05	0.000167	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-A—melanoma	1.6e-05	0.000164	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RAC1—melanoma	1.59e-05	0.000163	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CTNNB1—melanoma	1.57e-05	0.000161	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CDKN1A—melanoma	1.53e-05	0.000157	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PTEN—melanoma	1.53e-05	0.000157	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NFKB1—melanoma	1.52e-05	0.000156	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—UGT2B10—melanoma	1.49e-05	0.000152	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCB1—melanoma	1.48e-05	0.000152	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.47e-05	0.000151	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR4—melanoma	1.46e-05	0.00015	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-DRB1—melanoma	1.46e-05	0.000149	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ICAM1—melanoma	1.4e-05	0.000143	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HS3ST5—melanoma	1.38e-05	0.000142	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PRKCA—melanoma	1.37e-05	0.00014	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NRAS—melanoma	1.36e-05	0.00014	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ERCC2—melanoma	1.35e-05	0.000139	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD80—melanoma	1.35e-05	0.000138	CbGpPWpGaD
Rasagiline—BCL2—Immune System—KIT—melanoma	1.34e-05	0.000138	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGF—melanoma	1.33e-05	0.000136	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK3—melanoma	1.31e-05	0.000134	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP8—melanoma	1.25e-05	0.000128	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK1—melanoma	1.24e-05	0.000127	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EGFR—melanoma	1.24e-05	0.000127	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDH1—melanoma	1.24e-05	0.000127	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAP2K1—melanoma	1.19e-05	0.000122	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIK3CD—melanoma	1.18e-05	0.000121	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—KRAS—melanoma	1.17e-05	0.00012	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FGF2—melanoma	1.13e-05	0.000116	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.11e-05	0.000114	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PIK3CA—melanoma	1.08e-05	0.000111	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CG—melanoma	1.07e-05	0.00011	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNG—melanoma	1.06e-05	0.000109	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MDM2—melanoma	1.06e-05	0.000109	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLCB4—melanoma	1.05e-05	0.000107	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB2—melanoma	1.04e-05	0.000107	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—melanoma	1.03e-05	0.000106	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIK3CB—melanoma	1.03e-05	0.000106	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD4—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HRAS—melanoma	9.98e-06	0.000102	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIP4K2A—melanoma	9.85e-06	0.000101	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC6A11—melanoma	9.85e-06	0.000101	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDKN1B—melanoma	9.67e-06	9.91e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTAP—melanoma	9.58e-06	9.83e-05	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—melanoma	9.55e-06	9.79e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL2—melanoma	9.46e-06	9.7e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CD—melanoma	9.41e-06	9.64e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	9.37e-06	9.6e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—melanoma	9.29e-06	9.52e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTNNB1—melanoma	9.13e-06	9.36e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDKN1A—melanoma	8.92e-06	9.15e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTEN—melanoma	8.9e-06	9.13e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NFKB1—melanoma	8.86e-06	9.08e-05	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—melanoma	8.81e-06	9.03e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LUM—melanoma	8.54e-06	8.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PHGDH—melanoma	8.54e-06	8.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HPSE—melanoma	8.38e-06	8.59e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CUBN—melanoma	8.22e-06	8.43e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CB—melanoma	8.2e-06	8.41e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—melanoma	8.12e-06	8.33e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—STAT3—melanoma	7.96e-06	8.16e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NRAS—melanoma	7.94e-06	8.14e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SDHD—melanoma	7.94e-06	8.14e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CSPG4—melanoma	7.94e-06	8.14e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BSG—melanoma	7.94e-06	8.14e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GPAM—melanoma	7.69e-06	7.89e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK3—melanoma	7.61e-06	7.8e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK1—melanoma	7.24e-06	7.42e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGFR—melanoma	7.24e-06	7.42e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTEN—melanoma	7.09e-06	7.26e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—KRAS—melanoma	6.84e-06	7.01e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G6—melanoma	6.54e-06	6.71e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIK3CA—melanoma	6.28e-06	6.44e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—VCAN—melanoma	5.87e-06	6.02e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HRAS—melanoma	5.81e-06	5.96e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—melanoma	5.56e-06	5.7e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.56e-06	5.7e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.37e-06	5.5e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—melanoma	5.13e-06	5.26e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CA—melanoma	5e-06	5.12e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP17A1—melanoma	4.96e-06	5.08e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.89e-06	5.01e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	4.83e-06	4.95e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GNA11—melanoma	4.68e-06	4.8e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FASN—melanoma	4.58e-06	4.7e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC5A5—melanoma	4.51e-06	4.62e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GNAQ—melanoma	4.35e-06	4.46e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CD44—melanoma	4.35e-06	4.46e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.26e-06	4.37e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.22e-06	4.33e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP1B1—melanoma	4.17e-06	4.28e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—melanoma	4.08e-06	4.19e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.68e-06	3.77e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCB1—melanoma	3.44e-06	3.52e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PRKCA—melanoma	3.16e-06	3.24e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ERCC2—melanoma	3.14e-06	3.21e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.6e-06	2.66e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CG—melanoma	2.48e-06	2.54e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—melanoma	2.39e-06	2.45e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CD—melanoma	2.18e-06	2.23e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—melanoma	2.15e-06	2.2e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CB—melanoma	1.9e-06	1.95e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—melanoma	1.88e-06	1.93e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTEN—melanoma	1.64e-06	1.68e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CA—melanoma	1.16e-06	1.19e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—melanoma	9.45e-07	9.69e-06	CbGpPWpGaD
